Axogen, Inc. (AXGN) stock forecast and price target
Price $55.93 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($55.93)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $0.55 | +91.2% | $290M |
| Next fiscal year ends December 31, 2027 | $0.71 | +27.3% | $373M |
| Next quarter ends December 31, 2026 | $0.15 | +108.1% | $83M |
| Quarter after ends March 31, 2027 | $0.13 | +81.3% | $81M |
Consensus of the analysts covering Axogen, updated daily. In the last 30 days 6 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 6.0% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Axogen’s intrinsic value about 88% below today’s market value, and it scores 1.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Axogen stock price target?
The average 12-month target from 11 analysts is $59.27, 6.0% above the current price of $55.93 Targets range from $56.00 to $65.00.
Is Axogen a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 9 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Axogen expected to earn?
Analysts expect EPS of $0.55 for the fiscal year ending December 31, 2026 and $0.71 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.